R&D STRATEGY

R&D Strategies identify sources of innovation and prioritize opportunities through robust technical, clinical, regulatory, and commercial analysis.

  • Early Stage Innovation Sourcing
  • Therapeutic Area Strategy
  • Clinical Development Strategy
  • Portfolio Management

Early-stage Innovation Sourcing

Read More▼

Evaluate approaches for sourcing innovative technology, including the role of academia.

Read about how we helped a large Pharma/Biotech client:

SITUATION

  • Pharma client sought to evaluate more productive approaches to accessing early-stage technology

OUR APPROACH

  • Held in-depth discussions with leading academic institutions, investigators and VCs to identify key challenges and opportunities for pharma
  • Benchmarked approaches of other pharma for engaging the academic community
  • Developed roadmap of initiatives to drive collaboration with academia and access to IP
  • Detailed implementation plan for integration of client resources and transitioning this model into the organization

RESULT

  • Integrated strategy for the client to engage with VCs, academia, and innovative biotech companies
  • Framework for incorporating this novel approach into traditional pharma R&D organizational structure

Franchise Strategy

Read More▼

Determine technology white spaces that could synergistically improve a franchise's top line growth.

Read about how we helped a large Medtech/Diagnostic client:

SITUATION

  • Global medical technology company with a $1B+ cardiac surgical presence required additional high margin revenue generators as its business changed from surgery to catheter based interventions

OUR APPROACH

  • Via the lens of the cardiac surgical patient journey, analyzed the constellation of peri-operative unmet needs that could improve patient outcomes and physician performance
  • Considered devices and services across the spectrum of patient needs in order to reflect holistic changes in cardiac care and ability to achieve market dominance
  • Identified a range of white spaces and evaluated the rationale behind the technology and its proposed role in patient care

RESULT

  • Enabled client to look beyond cardiac surgical devices into opportunities such as diagnostic testing/monitoring, IT-based decision and patient support, and convergent drug delivery technologies

Portfolio Management & Rationalization

Read More▼

Evaluate and prioritize programs to determine their growth potential and strategic relevance.

Read about how we helped a small Pharma/Biotech client:

SITUATION

  • Emerging biotech focused on small molecule therapies in Oncology/Autoimmune needed to assess the strategic options for four key assets and determine the optimal path for their development and commercialization

OUR APPROACH

  • Analyze each program's potential role in the treatment paradigm and understand the product's positioning and commercial potential
  • Understand the deal landscape and determine the optimal timing for a partnering/exit to maximize return and provide the greatest likelihood of finding an appropriate partner
  • Prioritize programs based on expected return on investment

RESULT

  • Defined expectations for deal metrics by stage of development, partner characteristics, and deal structure
  • Provided clear understanding of the relative strategic value of each program, resulting in reprioritization of client's pipeline

Proven

Results complete
the circle.

Here are some of the challenges Back Bay has helped our clients meet:

Global biopharmaceutical company needed to prioritize and determine the commercial...
read more

European biotech and multinational nuclear medicine client sought positioning/promotion strategies for...
read more

See all impact studies.

Background Image